Latest article
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Consensus Suggestion of “Purchase” from Analysts
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) has received an average "buy" rating from the thirteen brokers covering the company, MarketBeat Ratings reports. Four...
Research hyperlinks muscle gene to kind 2 diabetes
People with type 2 diabetes tend to have poorer muscle function than...
